Synergistic Effects and Sex Differences in Anthropometric Measures of Obesity and Elevated High-Sensitivity C-Reactive Protein Levels by 김규리 et al.




Synergistic Effects and Sex Differences in
Anthropometric Measures of Obesity and Elevated
High-Sensitivity C-Reactive Protein Levels
Fatima Nari 1,2 , Bich Na Jang 1,2 , Gyu Ri Kim 3 , Eun-Cheol Park 2,3 and Sung-In Jang 2,3,*
1 Department of Public Health, Graduate School, Yonsei University, Seoul 03722, Korea; fatima@yuhs.ac (F.N.);
jbn2846@yuhs.ac (B.N.J.)
2 Institute of Health Services Research, Yonsei University, Seoul 03722, Korea; ecpark@yuhs.ac
3 Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Korea;
GYURIKIM@yuhs.ac
* Correspondence: jangsi@yuhs.ac; Tel.: +82-2-2228-1862
Received: 20 September 2020; Accepted: 7 November 2020; Published: 9 November 2020 
Abstract: Background: It remains unclear which anthropometric measure best predicts elevated
high-sensitivity C-reactive protein (hs-CRP) levels. This study investigated the association and
synergistic interaction of two obesity indices with elevated hs-CRP levels in a national sample of
Korean adults, stratified by sex. Methods: The present cross-sectional study used data from the
2015–2018 Korea National Health and Nutrition Examination Survey of 18,610 subjects aged ≥20 years
after excluding those with missing variables. Multiple logistic regression analyses and chi-squared
tests were performed to investigate the association between body mass index (BMI) and waist
circumference (WC) with elevated hs-CRP levels. Interaction analysis was used to examine the
synergistic effect between BMI and WC on the risk of having elevated hs-CRP levels. Results: Elevated
hs-CRP levels exceeding 3 mg/L were present in 9.3% and 7.5% of men and women, respectively.
The relationship between each obesity index and elevated hs-CRP levels was significant in women
(high WC (odds ratio [OR] = 1.77, 95% confidence interval [CI] = 1.24–2.54), high BMI (OR = 2.08, 95%
CI = 1.58–2.74)) but not in men (high WC (OR = 1.19, 95% CI = 0.86–1.64), high BMI (OR = 0.99, 95%
CI = 0.77–1.29)). Furthermore, combined measures of the two obesity indices and interaction analysis
results revealed a synergistic association in men (OR = 1.57, 95% CI = 1.33–1.85; relative excess risk
due to interaction (RERI) = 0.39, 95% CI = −0.09–0.86), and women (OR = 3.70, 95% CI = 3.09–4.43;
RERI = 0.85, 95% CI = −0.06–1.75). Conclusion: BMI and WC were significantly associated with
a risk of elevated hs-CRP levels in women but not in men. Nevertheless, significant synergistic
interactions were seen in combined measures of BMI and WC, regardless of sex. These findings
emphasize the need to use both measures of adiposity concurrently in the assessment of obesity and
when identifying cardiovascular risk.
Keywords: BMI; waist circumference; interaction analysis; inflammation; cardiovascular risk
1. Introduction
Obesity is a chronic disease that poses a great global burden, as it affects over one billion adults
throughout the world [1]. In South Korea, the prevalence of obesity in the population was estimated to
be 32.4% in 2015 [2,3].
Obesity has been linked to an increased risk of many different illnesses, including but not limited
to hypertension, metabolic syndrome, coronary heart disease, and other atherosclerotic diseases [4].
Additionally, elevated high-sensitivity C-reactive protein (hs-CRP), as an indicator of low-grade
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inflammation, has been considered a possible risk factor for cardiovascular diseases [5] associated with
obesity and visceral adiposity [6].
Hs-CRP levels have emerged as a useful biomarker for atherosclerotic processes and future
cardiovascular disease (CVD) risk [7], acting as a more sensitive alternative to the traditional CRP
marker [8–10]. Evidence suggests that adipose tissue is a major source of inflammatory cytokines, such
as tumor necrosis factor-α and interleukin-6. In turn, the presence of these cytokines in the circulation
stimulates inflammation and increases CRP levels in the liver [11]. Thus, a strong positive association
has been found between measures of obesity, such as waist circumference (WC) and body mass index
(BMI), and CRP levels [12,13].
However, with respect to the association between hs-CRP levels and obesity, prior studies have
shown that the relationship differs according to various factors, such as age, sex, and ethnicity [14].
Additionally, normal-weight individuals with metabolic dysfunction have greater cardiovascular risk
than metabolically healthy obese subjects in the Asian population when assessed using BMI [15]. This
indicates that one measure of obesity, such as BMI alone, cannot precisely quantify health risks in
different subgroups and populations [14].
Consequently, prior studies have advocated for the use of multiple measures of obesity rather than
one independent measure of obesity in assessing adverse health outcomes, such as cardiovascular risk.
A study carried out in the Norwegian adult population showed that the combined measure of BMI and
WC resulted in a worse prognosis of health indicators and lifestyle factors, such as unhealthy diet, low
physical activity, and elevated cardiovascular risk [16]. Ki et al. deemed that the use of BMI and WC
are both equally effective measures in identifying multiple cardiovascular risk factors in the Korean
population [17]. The study concluded that each individual index of obesity showed a significant, albeit
modest, association with cardiovascular risk factors. The authors then went on to recommend the use
of both indices to provide more insight regarding cardiovascular risk in Korean men and women [17].
Thus, our present study’s primary objective was to investigate the association between two obesity
indices, BMI and WC, and their combination with elevated hs-CRP levels in Korean adults. Our
secondary aim was to highlight any synergistic interactions of the use of combined BMI-WC measures
in our study population.
2. Materials and Methods
Our study used data derived from the 2015 to 2018 Korean National Health and Nutrition
Examination Survey (KNHANES). The KNHANES is a cross-sectional survey that uses a complex
multistage sampling method to analyze approximately 10,000 people annually. We excluded those
younger than 20 years because we deemed that the recommended guidelines for obesity assessment in
pediatric individuals [18] and adults above 20 years are very different. Furthermore, after excluding
those with missing data, we included 18,610 people in our study.
The main outcome measure in our study was elevated hs-CRP levels. According to the criteria set
by the American Heart Association and Centers for Disease Control and Prevention, an hs-CRP level
of >3.0 mg/L is defined as reflecting a high risk of developing future cardiovascular disease [19].
To classify general obesity, we used the criteria stipulated by the World Health Organization
(WHO) for general obesity in the Asian population [20]: A BMI higher than 25 kg/m2. To classify
central obesity, we used high WC as defined by the Korean Society for the Study of Obesity (KSSO). The
recommended cut-off point for waist circumference was ≥90 cm for women and ≥85 cm for men [21].
Data regarding sociodemographic characteristics and health behavior-related variables were all
added as potential confounders in this study. Sociodemographic characteristics included sex, age (20–34
years, 35–49 years, ≥50 years), education level (middle school degree or lower, high school degree,
university degree or higher), and income level per month, which was divided into four categories
(low, middle low, middle high, and high). Additionally, marital status was divided into married and
unmarried, and region was divided into urban and rural. Job classification was based on the Korean
Standard Occupational Classification (sixth revision) and was divided into four categories: White
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collar workers (office work), pink collar workers (sales and service), blue collar workers (agriculture,
forestry, fishery, and armed forces occupation) [22], and unemployed.
Smoking experience and alcohol drinking experience were classified as Never and Ever. Aerobic
exercise was classified based on the validated Korean version of the International Physical Activity
Questionnaire (IPAQ) [23]. Those who were coded in the “Yes” group were defined as those who met
recommended levels of aerobic exercise, which was up to 150 min per week of moderate-intensity
exercise or up to 75 min per week of vigorous exercise. Otherwise, they were coded into the “No” group.
Chronic diseases included in this study were hypertension, diabetes mellitus, stroke, and myocardial
infarction, and the number of comorbidities were grouped into three categories: 0 comorbidities,
1 comorbidity, and ≥2 comorbidities. Subjective health condition was divided into Good, Normal,
and Bad.
Multivariable logistic regression was used to analyze the association between general and central
obesity with elevated hs-CRP levels in the study population, which were also carried out in subgroups.
P-values less than 0.05 were considered statistically significant. The three additive interaction measures
used in our study were relative excess risk due to interaction (RERI); the proportion of disease among
those with both exposures that is attributable to their interaction, i.e., Attributable Proportion (AP);
and Synergy Index (SI). We also estimated their corresponding 95% confidence interval (CI) using the
method described by Homer and Lemeshow [24]. They were calculated according to the following
equations: RERI = OR11 − OR10 − OR01 + 1, AP = RERI/OR11, and SI = (OR11–1)/(OR01–1) +
(OR10–1) [25]. If RERI and AP did not equal 0 and SI exceeded unity, then a synergistic effect was
considered present. In contrast, if RERI was less than 0, then the interaction effect between the two
exposures was considered to be antagonistic [25]. All statistical analyses were conducted using SAS
9.4 software (SAS Inc., Cary, NC, USA).
3. Results
The study population’s general characteristics are shown in Table 1. In total, 18,610 people were
included in this study, of which 8842 were men and 9768 were women. The prevalence of elevated
hs-CRP in those with high WC was 11.0% for men and 8.0% for women, and in those with high BMI, it
was 7.2% and 9.0% in men and women, respectively. Men and women with both high BMI and high
WC had a prevalence of elevated hs-CRP of 12.0% and 15.3%, respectively.











Yes No Yes No
n (%) n (%) n (%) n (%) n (%) n (%)
Total 8842 (100.0) 818 (9.3) 8024 (90.7) 9768 (100.0) 732 (7.5) 9036 (92.5)
Obesity <0.0001 <0.0001
Normal 4786 (54.1) 387 (8.1) 4399 (91.9) 6409 (65.6) 302 (4.7) 6107 (95.3)
High WC a 427 (4.8) 47 (11.0) 380 (89.0) 476 (4.9) 38 (8.0) 438 (92.0)
High BMI b 1069 (12.1) 77 (7.2) 992 (92.8) 781 (8.0) 70 (9.0) 711 (91.0)
High BMI & WC 2560 (29.0) 307 (12.0) 2253 (88.0) 2102 (21.5) 322 (15.3) 1780 (84.7)
Age <0.0001 0.6737
20–34 1766 (20.0) 118 (6.7) 1648 (93.3) 1995 (20.4) 160 (8.0) 1835 (92.0)
35–49 2440 (27.6) 185 (7.6) 2255 (92.4) 3103 (31.8) 203 (6.5) 2900 (93.5)
50≤ 4636 (52.4) 515 (11.1) 4121 (88.9) 4670 (47.8) 369 (7.9) 4301 (92.1)
Education Level <0.0001 0.0024
Middle school or
lower 2125 (24.0) 277 (13.0) 1848 (87.0) 2949 (30.2) 265 (9.0) 2684 (91.0)
High School 3105 (35.1) 259 (8.3) 2846 (91.7) 3208 (32.8) 217 (6.8) 2991 (93.2)
University degree
or higher 3612 (40.9) 282 (7.8) 3330 (92.2) 3611 (37.0) 250 (6.9) 3361 (93.1)












Yes No Yes No
n (%) n (%) n (%) n (%) n (%) n (%)
Income Level <0.0001 <0.0001
Low 1409 (15.9) 202 (14.3) 1207 (85.7) 1604 (16.4) 159 (9.9) 1445 (90.1)
Middle Low 2108 (23.8) 210 (10.0) 1898 (90.0) 2415 (24.7) 188 (7.8) 2227 (92.2)
Middle High 2513 (28.4) 187 (7.4) 2326 (92.6) 2806 (28.7) 211 (7.5) 2595 (92.5)
High 2812 (31.8) 219 (7.8) 2593 (92.2) 2943 (30.1) 174 (5.9) 2769 (94.1)
Marital Status 0.9107 0.1904
Married 6457 (73.0) 596 (9.2) 5861 (90.8) 6644 (68.0) 482 (7.3) 6162 (92.7)
Unmarried 2385 (27.0) 222 (9.3) 2163 (90.7) 3124 (32.0) 250 (8.0) 2874 (92.0)
Job Classification <0.0001 <0.0001
White 2613 (29.6) 195 (7.5) 2418 (92.5) 2351 (24.1) 134 (5.7) 2217 (94.3)
Pink 928 (10.5) 71 (7.7) 857 (92.3) 1574 (16.1) 90 (5.7) 1484 (94.3)
Blue 2968 (33.6) 277 (9.3) 2691 (90.7) 1448 (14.8) 92 (6.4) 1356 (93.6)
Unemployed 2333 (26.4) 275 (11.8) 2058 (88.2) 4395 (45.0) 416 (9.5) 3979 (90.5)
Region 0.9351 0.3958
Urban 4128 (46.7) 383 (9.3) 3745 (90.7) 4671 (47.8) 339 (7.3) 4332 (92.7)
Rural 4714 (53.3) 435 (9.2) 4279 (90.8) 5097 (52.2) 393 (7.7) 4704 (92.3)
Smoking 0.0271 0.0020
Never 1945 (22.0) 155 (8.0) 1790 (92.0) 8572 (87.8) 616 (7.2) 7956 (92.8)
Ever 6897 (78.0) 663 (9.6) 6234 (90.4) 1196 (12.2) 116 (9.7) 1080 (90.3)
Drinking <0.0001 0.0361
Never 1158 (13.1) 144 (12.4) 1014 (87.6) 2179 (22.3) 186 (8.5) 1993 (91.5)
Ever 7684 (86.9) 674 (8.8) 7010 (91.2) 7589 (77.7) 546 (7.2) 7043 (92.8)
Aerobic Exercise 0.0082 0.0152
No 4605 (52.1) 462 (10.0) 4143 (90.0) 5534 (56.7) 446 (8.1) 5088 (91.9)
Yes 4237 (47.9) 356 (8.4) 3881 (91.6) 4234 (43.3) 286 (6.8) 3948 (93.2)
Subjective Health
Condition <0.0001 <0.0001
Good 2875 (32.5) 185 (6.4) 2690 (93.6) 2584 (26.5) 131 (5.1) 2453 (94.9)
Normal 4546 (51.4) 433 (9.5) 4113 (90.5) 5176 (53.0) 388 (7.5) 4788 (92.5)
Bad 1421 (16.1) 200 (14.1) 1221 (85.9) 2008 (20.6) 213 (10.6) 1795 (89.4)
Number of
Chronic Diseases <0.0001 0.0047
0 5661 (64.0) 440 (7.8) 5221 (92.2) 6884 (70.5) 483 (7.0) 6401 (93.0)
1 1762 (19.9) 219 (12.4) 1543 (87.6) 1563 (16.0) 130 (8.3) 1433 (91.7)
≥2 1419 (16.0) 159 (11.2) 1260 (88.8) 1321 (13.5) 119 (9.0) 1202 (91.0)
a As defined by the Korean Society for the Study of Obesity (KSSO), the cut-off value for waist circumference (WC)
is ≥ 90 cm for women and ≥ 85 cm for men; b As set by the World Health Organization (WHO), a body mass index
(BMI) higher than 25 kg/m2 indicates general obesity in the Asian population.
Table 2 shows the association of BMI and WC with the risk of elevated hs-CRP levels. Women
with high WC or high BMI had a statistically significant higher risk of elevated hs-CRP levels than
those in the normal range, while men did not exhibit any significant association (men: High WC (odds
ratio [OR] 1.19, 95% CI 0.86–1.64), high BMI (OR 0.99, 95% CI 0.77–1.29); women: WC (OR 1.77, 95% CI
1.24–2.54), high BMI (OR 2.08, 95% CI 1.58–2.74)). Furthermore, participants who had concurrent high
BMI and high WC had the greatest risk of elevated hs-CRP levels compared to those in the normal
range (men: OR 1.57, 95% CI 1.33–1.85; women: OR 3.70, 95% CI 3.09–4.43). The additive interaction
results in men were as follows: RERI was 0.39 (95% CI, −0.09–0.86), SI was 3.16 (95% CI 2.69–3.64),
and AP was 0.25 (95% CI −0.23–0.72). The results in women were as follows: RERI was 0.85 (95% CI
−0.06–1.75), SI was 1.46 (95% CI 0.55–2.36), and AP was 0.23 (95% CI −0.68–1.13).
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Table 2. Association of BMI and WC with elevated high-sensitivity C-reactive protein (hs-CRP) levels.
Variables
Elevated hs-CRP Levels ≥3 mg/L
Male Female
Adjusted OR 95% CI Adjusted OR 95% CI
Obesity
Normal 1.00 - 1.00 -
High WC a 1.19 (0.86–1.64) 1.77 (1.24–2.54)
High BMI b 0.99 (0.77–1.29) 2.08 (1.58–2.74)
High BMI & WC c 1.57 (1.33–1.85) 3.70 (3.09–4.43)
Age
20–34 1.00 - 1.00 -
35–49 1.21 (0.92–1.60) 0.73 (0.57–0.92)
50≤ 1.50 (1.13–2.00) 0.73 (0.55–0.96)
Education Level
Middle school or lower 1.15 (0.90–1.45) 0.91 (0.69–1.19)
High School 0.94 (0.77–1.15) 0.87 (0.70–1.07)
University degree or
higher 1.00 - 1.00 -
Income Level
Low 1.37 (1.07–1.75) 1.18 (0.90–1.54)
Middle Low 1.13 (0.91–1.40) 1.04 (0.83–1.31)
Middle High 0.93 (0.75–1.14) 1.13 (0.92–1.41)
High 1.00 - 1.00 -
Marital Status
Married 1.00 - 1.00 -
Unmarried 1.23 (1.00–1.50) 1.01 (0.84–1.21)
Job Classification
White 1.00 - 1.00 -
Pink 1.12 (0.88–1.43) 1.46 (1.16–1.84)
Blue 1.01 (0.80–1.27) 0.95 (0.69–1.30)
Unemployed 0.94 (0.70–1.27) 0.93 (0.69–1.26)
Region
Urban 1.08 (0.93–1.25) 0.99 (0.85–1.16)
Rural 1.00 - 1.00 -
Smoking
Never 1.00 - 1.00 -
Ever 1.06 (0.88–1.29) 1.21 (0.97–1.51)
Drinking
Never 1.00 - 1.00 -
Ever 0.87 (0.71–1.06) 0.96 (0.80–1.15)
Aerobic Exercise
No 1.02 (0.88–1.19) 1.12 (0.95–1.31)
Yes 1.00 - 1.00 -
Subjective Health Condition
Good 1.00 - 1.00 -
Normal 1.42 (1.18–1.71) 1.40 (1.14–1.73)
Bad 1.86 (1.48–2.33) 1.73 (1.36–2.20)
Number of Chronic Diseases
0 1.00 - 1.00 -
1 1.22 (1.01–1.48) 0.90 (0.71–1.14)
≥2 0.91 (0.73–1.14) 0.74 (0.57–0.96)
a As defined by the Korean Society for the Study of Obesity (KSSO), the cut-off value for waist circumference is ≥ 90
cm for women and ≥ 85 cm for men; b As set by the World Health Organization (WHO), a BMI higher than 25 kg/m2
indicates general obesity in the Asian population; c Additive analysis results. In men, relative excess risk due to
interaction = 0.39; 95% CI (−0.09–0.86), Synergy Index = 3.16 (95% CI 2.69–3.64), Attributable Proportion = 0.25; 95%
CI (−0.23–0.72). In women, relative excess risk due to interaction = 0.85; 95% CI (−0.06–1.75), Synergy Index = 1.46
(95% CI 0.55–2.36), Attributable Proportion = 0.23; 95% CI (−0.68–1.13).
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The subgroup analysis of the relationship of elevated hs-CRP risk with age, smoking, drinking,
and number of chronic diseases is presented in Figures 1 and 2 for men and women, respectively,
with high BMI and high WC. Generally, men and women who had both high BMI and high WC
were more significantly associated with all variables than either measure of adiposity individually.
In addition, men with both high BMI and high WC and who were younger (20–34 years; OR 2.73, 95%
CI 1.77–4.20), never smokers (OR 2.07, 95% CI 1.43–3.01), and who were seemingly healthy with no
presence of comorbidities (OR, 1.83, 95% CI 1.47–2.28) had a higher risk of elevated hs-CRP levels
than their respective counterparts. There was no noticeable difference in the risk of elevated hs-CRP
between never and ever drinkers in men. Similarly, for women with concurrent high BMI and high
WC and who were younger (20–34 years; OR 11.55, 95% CI 7.67–17.40), ever smokers (OR 5.86, 95%
CI 3.70–9.27), ever drinkers (OR 3.89, 95% CI 3.16–4.79), and who were seemingly healthy with no
presence of comorbidities (OR 4.40, 95% CI 3.55–5.47) had a higher risk of elevated hs-CRP levels than
their respective counterparts.
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Figure 1. Forest plots of subgroup analysis results in men.
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Figure 2. Forest plots of subgroup analysis results in women.
4. Discussion
Our present study utilized cross-sectional data from KNHANES to investigate the association
of obesity and central obesity with elevated hs-CRP levels. Our findings suggest that while obesity
and central obesity were both individually associated with elevated hs-CRP levels in women, such a
relationship was not present in men. Moreover, those with both obesity indices had the highest risk of
elevated hs-CRP levels in Korean men and women compared to either individual index of obesity.
Our findings confirm previous research findings concerning the relationship between the adiposity
measures of WC and BMI and systemic inflammation [12,26].
Perhaps one of the most significant findings of our present study was the sex difference between
measures of adiposity and hs-CRP levels. Female individuals consistently exhibited a higher risk
of elevated hs-CRP levels for both measures of obesity than men, both individually and combined.
Our findings are supported by a number of other studies, where a strong correlation for both WC
and BMI with hs-CRP was seen in women [13,26]. In contrast to our study’s results, an investigation
carried out in the Korean population regarding the effects of individual BMI and WC indices on
cardiovascular risk identified significant relationships in both sexes [17]. Nevertheless, a prior study
in Korea showed that sarcopenic obesity was linked to elevated hs-CRP levels in women but not in
men [27]. In a multivariate analysis study carried out in Mediterranean women with obesity, BMI
and WC were independently correlated with hs-CRP concentration [28]. Whereas there is no concrete
evidence regarding the sex disparity in the relationship between obesity and elevated hs-CRP levels,
two mechanisms have been suggested. First, the secretion of estrogen in female individuals may play
a role in the etiology of inflammation [29], thereby leading to a more pronounced effect on hs-CRP
levels. Second, women generally have higher levels of body and visceral fat than men [30], with a
consequent elevation in hs-CRP levels and cardiovascular risk.
Whereas the use of BMI as an obesity index has proven valuable and carries great implication [31],
it also comes with its share of limitations. As previously mentioned, at a similar BMI, women have
a greater percentage of body fat than men. The use of another measure of obesity, namely WC, to
increase the reliability of adiposity evaluation, is encouraged. Our study’s data reflect the difference in
the association of obesity indices, showing a higher prevalence of elevated hs-CRP levels in women
than in men among people with obesity. Thus, in accordance with prior findings, the presence of a
high BMI and abdominal obesity as measured using WC and their influence on the risk of elevated
hs-CRP levels was significant in both men and women [16].
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To the best of our knowledge, this study is one of the few that carried out an interaction analysis
to examine the possible additive interaction between high BMI and high WC with respect to elevated
hs-CRP levels in the Korean population. The results of our study revealed that the effect of either factor
on elevated hs-CRP levels was significantly increased by the other, which is consistent with an additive
interaction [32]. The European guidelines for the management of obesity also concluded that greater
BMI is associated with higher metabolic and CVD risk due to the accumulation of intra-abdominal
fat, as measured by waist circumference [33]. Likewise, the 2018 guidelines for obesity published
by the KSSO revealed that the risk of comorbidities, such as diabetes and hypertension, was severe
in individuals with a BMI ≥25 kg/m2 and with abdominal obesity [34]. According to the WHO, the
rationale for a lower BMI cut-off point for obesity (≥25 kg/m2) is that Asians generally have a greater
percentage of body fat compared to non-Asians at the same BMI [20,34].
In the subgroup analysis, men and women in their 20s with concurrent general and central obesity
had the highest risk of elevated hs-CRP levels, and the risk decreased with increasing age. This finding
is consistent with those of several other studies. One study stated that older women with obesity were
less likely to have clinically raised hs-CRP levels than younger women with obesity, although this
trend was not seen in men [31]. Park et al. showed that obesity in younger subjects, especially those
younger than 60 years of age, were more likely to have elevated hs-CRP levels than older subjects [27].
A study carried out in younger Koreans revealed that obese individuals were positively associated
with hs-CRP levels in the upper tertile (i.e., >0.5 mg/L) [35]. In addition, while obesity in younger and
middle-aged adults is associated with higher cardiovascular risk and other negative health outcomes,
this does not seem to be the case in older adults [27,36]. In fact, high BMI in the aging population
carries a somewhat protective effect, and while the mechanism is not fully understood, it is associated
with a decreased risk of morbidity and death [37].
Furthermore, while smoking and drinking did not show a statistically significant association in
men, it was associated with elevated hs-CRP levels in women. In contrast, the relationship between
smoking, obesity, and markers of inflammation has already been established in prior studies. A
study by Wafika et al. suggested that hs-CRP levels in men who were smokers and were both obese
and had central obesity were higher than those in smokers with normal anthropometric values [38].
Additionally, another study by Mazen et al. carried out in women revealed that there were no significant
differences in hs-CRP levels between smokers and nonsmokers [39,40].
Another point to note from our subgroup analysis results is the fact that individuals who were
seemingly healthy were at a higher risk of having elevated hs-CRP levels than those who had one or
more chronic diseases. This finding could be supported by a study that revealed that hs-CRP levels
were higher in those who had diabetes than those who did not. An explanation that was offered was
that diabetics take medication, which could have lowered the level of hs-CRP in those individuals [41].
Therefore, the finding that healthier individuals had a higher risk of elevated hs-CRP levels may be
attributed to the fact that those who were sick took medications and were more health-conscious.
This study has several limitations. First, as this was a cross-sectional study, we could not infer
the causality and temporality of any relationship. Specifically, the directionality between the two
obesity indices and inflammation could not be determined. In other words, we cannot be sure whether
elevated hs-CRP levels were a cause or consequence of obesity. Second, we used a single assessment of
cardiovascular risk, hs-CRP levels, in our study, which may have affected the variability of our study.
Nevertheless, our study’s main strength lies in the fact that we investigated the synergistic
relationship and sex differences between the combined obesity indices of BMI and WC and elevated
hs-CRP levels. Second, our study included a large and homogenous national sample and investigated
the sex differences in the association of BMI and WC with elevated hs-CRP levels.
5. Conclusions
Our study’s findings have important methodological implications, with conclusions that both
BMI and WC were independently associated with elevated hs-CRP levels in women but not in men.
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In addition, our study provides novel information, as a synergistic interaction effect was seen with
concurrent BMI and WC and presented a higher risk of elevated hs-CRP levels in both sexes.
Hence, considering the public health burden of both obesity and elevated hs-CRP levels,
obesity-targeted prevention and management strategies are warranted to prevent and ameliorate
future inflammation and risk of CVD.
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